The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of dose-dense chemotherapy as first-line treatment of advanced ovarian cancer patients after non-optimal debulking.
 
Alexey Rumyantsev
Stock and Other Ownership Interests - Merck Sharp & Dohme; Pfizer; Sanofi
Honoraria - BioCad
Speakers' Bureau - AstraZeneca; BioCad
Travel, Accommodations, Expenses - AstraZeneca; BioCad
 
Alexandra Tyulyandina
Speakers' Bureau - AstraZeneca/MedImmune; BioCad; Merck Sharp & Dohme; Pfizer; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BioCad
 
Ilya Pokataev
Speakers' Bureau - AstraZeneca/MedImmune; BioCad; Roche; Sanofi
Travel, Accommodations, Expenses - BioCad; Lilly; Roche
 
Konstantin Morkhov
No Relationships to Disclose
 
Valentina Mikhailovna Nechuskina
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Speakers' Bureau - AstraZeneca; BioCad; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche